HomeMy WebLinkAboutAmendment re Healthcare Authority JEFFERSON COUNTY
BOARD OF COUNTY COMMISSIONERS
AGENDA REQUEST
TO: Board of County Commissioners
Mark McCauley,County Administrator
FROM: David Fortino
DATE: November 18,2024
SUBJECT: Amendment to HCA Grant Contract for the Residential Substance Abuse
Treatment Program.
STATEMENT OF ISSUE:
This Amendment to the HCA grant contract for Residential Substance Abuse Treatment will allow work to
continue that has helped address behavioral health and substance use disorders among the inmate population
of the Jefferson County Jail.
ANALYSIS:
This contract continues the Residential Substance Abuse Treatment program at the Jefferson County Jail that
provides an opportunity for incarcerated individuals in our community to engage in inpatient treatment
services locally, and gain a head start on their road to recovery. Additionally, this program enhances existing
Substance Use Disorder(SUD) services, such as Relapse Prevention and Substance Use Disorder
Assessments, as well as Behavioral Health Services.
FISCAL IMPACT:
The HCA Grant Contract Provides $158.100 along with $39,525 in matching county funds.
RECOMMENDATION:
Approve Contract Amendment - Washington State Healthcare Authority — Residential Substance Abuse
Treatment in Prisons and Jails and delegate the authority to sign oft on behalf of the county to Chief of
Corrections David Fortino.
REVIEWED BY:
� ell
Mark Mc('aul Vounty Administrator Date
CONTRACT REVIEW FORM clear Form
(INSTRUCTIONS ARE ON THE NEXT PAGE)
CONTRACT W ITH: Washington State Healthcare Authority Contract No: K4880-5
Contract I-or- Residential Sutwame Abuse Treatment in Pnsons and Jails 1-enn: 1
COI N7'>r' DEPARTMENT: Jefferson County Sherdrs Office
Contact Person: David Fortino
Contact Phone: 360-3"-9743
Contact email: dr«tmCou jenerson wa us
AMOI N'T: 5'58 too PROCESS: Exempt from Bid Process
Ret,enue: MA Cooperative Purchase
Expenditure: N/A Competitive Sealed Bid
`latching l.unds Required: $39525 Small Works Roster
Sources(s)of%latching Funds Vendor List Bid
Fund a 001.1W-000 RFP or RFQ
Munis Org/Obj oot-18o-000 Other.State Grant
APPROVAL STEPS:
STEP 1: DEPAI41 NI FAT CERTIFIES COMPLIANCE w ITH JCC 3.55.t)80 AND CHAPTER 42.23 RC W
CERTIFIED: ❑ N/A:�
ttinaturr � tLla e --
STEP 2: DEPARTMENT CERTIFIES THE PERSON PROPOSED FOR CONTRACTING %ITH THE
COUNTY (CONTRACTOR) HAS NOT BEEN DEBARRED BY ANY FEDERAL, STATE, OR LOCAL
AGENCY.
CERTIFIED: ❑ N/A:
Signature va
STEP 3: RISK MANAGEMENT REVIEVI (Hill be added electronicalh through Laserriche):
Electronically approved by Risk Management on 11/15/2024.
STEP 4: PROSECUTING ATTORNEY REVIE% (will be added electronicalh through Laserfiehe):
Electronically approved as to form by PAO on 11/8/2024.
Thank you for making the changes. State language -- cannot change.
STEP 5: DEPARTMENT MAKES REVISIONS arc RESUBMITS TO RISK MANAGEMENT AND
PROSECI TING ATTORNEY(IF REQUIRED).
STEP 6: CONTRACTOR SIGNS
STEP 7: SUBMIT TO BOCC FOR APPROVAL
1
Docusign Envelope ID FE1 F2FC2-0500-4C5F-BDB7-207624628C21
INTERAGENCY AGREEMENT HCA Contract No.: K4880
Washington State rit�l AMENDMENT Amendment No.: 5
Health Care Utho for RESIDENTIAL
SUBSTANCE ABUSE
TREATMENT in PRISONS
and JAILS
THIS AMENDMENT TO THE INTERAGENCY AGREEMENT is between the Washington State Health Care
Authority and the party whose name appears below, and is effective as of the date set forth below.
CONTRACTOR NAME CONTRACTOR doing business as (DBA)
Jefferson, County of Jefferson County Jail
CONTRACTOR ADDRESS CONTRACTOR CONTRACT MANAGER
79 Elkins Road Name: David Fortino
Port Hadlock, WA 98339-9700 Email: dfortinoCaco iefferson wa.us
AMENDMENT START DATE CONTRACT END DATE
October 1, 2024 September 30, 2025
Prior Maximum Contract Amount Amount of Increase Total Maximum Compensation
$594,131 $158,100 $752,231
WHEREAS, HCA and Contractor previously entered into Interagency Agreement K4880 for Residential
Substance Abuse Treatment in prisons and jails, and-,
WHEREAS, HCA and Contractor wish to amend the Interagency Agreement pursuant to Section 4.3,
Amendments, to extend the term, add funding for federal fiscal year 2025, update the attachments, and to
update the Statement of Work,
NOW THEREFORE, the parties agree the Interagency Agreement is amended as follows:
1. Section 3.2, Term, Subsection 3.2.1 is amended to extend the end date from September 30, 2024 to
September 30, 2025.
2. Section 3.3, Compensation is amended to increase the Total Maximum Compensation by$158,100, from
$594,131 to$752,231. All internal references to the Total Maximum Compensation amount are updated
accordingly.
3. Attachment 4, Federal Subaward Identification, K4880-05, is incorporated herein and attached hereto.
4. Attachment 7, Quarterly Report Template, is replaced in its entirety and is incorporated herein and
attached hereto.
5. Attachment 8, Standards of Care for Opioid Use Disorder, is replaced in its entirety and is incorporated
herein and attached hereto.
6. Attachment 9, Department of Justice(DOJ) Office of Justice Programs Bureau of Justice Assistance
Terms, is attached hereto, and incorporated herein as an attachment to the Contract.
7. Schedule A-2, Statement of Work, October 1, 2024- September 30, 2025, is incorporated herein and
attached hereto.
8. This Amendment is effective October 1, 2024 ("Effective Date").
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FETF2FC2-0500-4C5F-BDB7-207624628C2I
9 All capitalized terms not otherwise defined herein have the meaning ascribed to them in the Interagency
Agreement
10 All other terms and conditions of Interagency Agreement K4880 remain unchanged and in full force and
effect
The parties signing below warrant that they have read and understand this Amendment and have authority to
execute the Amendment This Amendment will be binding on HCA only upon signature by all parties
CONTRACTOR SIGNA'URE -1R,NTED NAME ANC 'ITLE GATE SIGNED
MCA SIGNATURE PRINTED NAME ANC"T_E DATE SIGNED
off•• 11kirldrie HoweRon
Deputy Contracts Administrator 1 1!7/2024
:kppru%rJ a. to WMI mil�
W- 1 for 11/08/2024
Philip C Hun uckcr Date
t Iiiet Ci%t1 L)cputN Pn,.rcuunu .\Uurnr*,
Washingtor State Substance Abuse T•eatment Services
Health Care Authority HCA Contract No K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BDB7-20762462BC21
ATTACHMENT 4
Federal Subaward Identification
K4880-05
1. Federal Awarding Agency Department of Justice
15PBJA-22-GG-00502
2. Federal Award Identification Number(FAIN) 15PBJA-23-GG-01570
3. Federal Award Date 09-28-2019
4. Assistance Listing Number and Title 16.593- Residential Substance AbuseTreatment for State Prisoners
5. Is the Award for Research and Development? ❑ Yes ® No
Leah Coberly, Deputy Division Director
6. Contact Information for HCA's Awarding Official WA State Health Care Authority
Division of Behavioral Health and Recovery
leah.coberlv .hca.wa.Qov
7. Subrecipient name(as it appears in SAM.gov) Jefferson, County of
8. Subrecipient's Unique Entity Identifier(UEI) LP11 B7JKFN38
9. Subaward Project Description Residential Substance Abuse Treatment
(RSAT) for State Prisoners Program
10. Primary Place of Performance 98339-9700
11, Subaward Period of Performance 10/1/2024-9/30/2025
12. Amount of Federal Funds Obligated by this Action $158,100
13 Total Amount of Federal Funds Obligated by HCA $158,100
to the Subrecipient, including this Action
14 Indirect Cost Rate for the Federal Award 10%
(including if the de minimis rate is charged)
This Contract is subject to 2 CFR Chapter 1, Part 170 Reporting Sub-Award and Executive Compensation Information. The
authorized representative for the Subrecipient identified above must answer the questions below. If you have questions or
need assistance, please contact subreci i ntmonitoring d',hca.wa oQv_.
1. Did the Subrecipient receive (1) 80% or more of its annual gross revenue from federal contracts, subcontracts,
grants, loans, subgrants, and/or cooperative agreements; and (2) $25,000,000 or more in annual gross revenues
from federal contracts,subcontracts,grants, loans, subgrants,and/or cooperative agreements?
❑ YES ❑ NO
2. Does the public have access to information about the compensation of the executives in your business or
organization through periodic reports filed under section 13(a)or 15(d)of the Securities Exchange Act of 1934(15
U.S.C. 78m(a), 78o(d)) or section 6104 of the Internal Revenue Code of 1986?
❑YES ❑ NO
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BD87-207624628C21
ATTACHMENT 7
Quarterly Report Template
1 Does your RSAT Program use evidence-based treatment services?
A Yes/No
B If yes. please describe the evidence-based treatment services
2 Please enter the number of treatment staff who work directly with participants in the
Residential Substance Abuse Treatment (RSAT) program since the beginning of grant
funding When answering 'A' please count all treatment staff regardless of funding source Staff
would be all treatment employees including but not limited to program managers case managers.
and clinicians Do NOT count the number of mentors, volunteers, or interns
A Number of treatment staff
B Of those reported in A' how many are paid for at least partially using BJA program funds.
including matching funds?
3 Please enter the amount of funds from all sources (In dollars) spent In your RSAT program
during the reporting period for the following areas
Funds Spent during Quarter BJA Funds Non-BJA Funds (All
Other Sources)
Personnel
Fringe benefits
Supplies/Equipment
Contract/consultant fees
Construction
Indirect costs
Other
JAIU• PROGRAMS
4 During the reporting period. using BJA program funds including matching funds. did you pay
for training for treatment staff to be cross trained in the jail/prison-based portion of the RSAT
program?
A Yes/No(If No. go to Question 8)
5 Please enter the number of treatment staff members who were cross trained in the
jail/prison-based portion of the RSAT program since the beginning of the program This
information should be based on the number of treatment staff who received training in the
implementation of assessment instruments. motivational interviewing(MI)techniques, accountability
training or addiction-related trainrngs as well as the number of treatment staff who received officer
training and other security training sessions
A Number of treatment staff cross trained _
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BDB7-207624628C21
6 During the reporting period. using BJA program funds including matching funds, did you pay
for training for custody staff to be cross trained in the jail/prison-based portion of the RSAT
program?
A. Yes/No(lf No. go to Question 8)
7 Please enter the number of custody staff members who were cross trained in the
jail/prison-based portion of the RSAT program since the beginning of the program. This
information should be based on the number of uniformed officers who received training in the
implementation of assessment instruments, MI techniques, accountability training, or addiction-
related tra►nings, as well as the number of treatment staff who received officer training and other
security training sessions
A. Number of custody staff cross trained
The following auestions pertain to individuals who are receiving services in your RSAT program The
following sections include the following: Risk Assessment and Treatment Planning,Number of
Participants Receiving Services Services Provided Program Completion Alcohol and Substance
Involvement:and Court and Criminal Involvement For these auestions please report the number of
individuals that is equal to the proportion of the federal funds(plus matching funds)of your total
annual budget for the RSAT program For example if the BJA RSAT grant(plus matching funds)
accounts for 65 percent of the total annual budget then please report on 65 percent of the program
oarticiyants When applying the percentage please round to the nearest whole number.Similarly,if
BJA RSAT funds(plus matching funds)are paving for a specific number of beds/treatment spaces
within Your facility please report on those individuals who are occupying those beds/treatment
spaces.
Number of Participants Receiving Services
8. Of those who entered the jail/prison-based portion of the RSAT program, please enter the
number of jail/prison/juvenile-based participants for the following measures.
Measure Cumulative Total
Total number of jail/prison-based participants enrolled as of the
last day of the reporting period
Number of NEW jail/prison-based participants admitted during
the reporting period
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BDB7-207624628C21
Risk Assessment and Treatment Planning
9. Of those who entered the jail/prison-based portion of the RSAT program, please enter the
number of jail/prison/juvenile-based participants for the following measures. Please only
include those individuals who have been admitted to the RSAT program.
Measure Cunwlative Total
Number of jail/prison-based participants administered a risk and
needs assessment
Number of jail/prison-based participants with high criminogenic
risks/needs
Number of jail/prison-based participants with an individualized
treatment plan. Number should not exceed the number of new
participants indicated in question 10
10. Are risk assessment screening tool results used in determining who is admitted as a
participant into the RSAT Program?A risk and needs assessment is an instrument to help
identify factors that may lead a participant to reoffend and services needed services to
minimize those risks. The risk and needs assessment does not need to have been
completed during the reporting period and could be completed by an outside entity.
A. Yes/No
11. Please name the risk assessment instrument(s)that is used to assess risk/need.
Services Provided
12. Please enter the number of jail/prison-based participants who were provided services
during the reporting period with BJA program funds, including matching funds, through
the following treatment components:
A. Substance abuse and treatment services
B. Cognitive and behavioral services(cognitive behavioral services include interventions that address
criminal thinking and antisocial behavior)
C. Employment services
D. Housing services
E. Mental health services
F. Other services
G. Please explain other services
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BDB7-207624628C21
13. Please enter the number of jail/prison-based participants who were provided with
transitional planning services with BJA program funds, including matching funds,
since the beginning of grant funding. To provide transitional planning services. the RSAT
program must work with clients to develop individualized post-release plans that address each clients
needs in terms of housing, employmenbfinancial support, and ongoing therapeutic needs. These
include enrollment in Medicaid or subsidized insurance programs, where available. They also include
prerelease engagement with the community correctional agency that will be providing post-release
supervision of the client, where relevant. Note:Blanket referrals to community self-help programs do
not constitute "transitional planning services "
Medication Assisted Treatment
The following questions ask about any Medication Assisted Treatment(MAT)participants may be
receiving within your program during the reporting period BJA supports the right of individuals to
have access to aoprooriate MAT under the care and prescription of a physician BJA recoanizes that
not all communities may have access to MAT due to lack of ohvsicians who are able to prescribe and
oversee clients usina anti-alcohol and opioid medications.
14. If your treatment program includes MAT,which of the following medications are you
utilizing? Select all that apply.
A. We do not provide MAT(Skip next question)
B. We do not have access to MAT(Skip next question)
C Naltrexone(Vivitrol®, Depot naltrexone)
D Buprenorphine or Buprenorphine/Naloxone(Bup/NX) (Suboxone®,)
E. Methadone
15. Of the total participants enrolled in your program, how many were deemed eligible for MAT
and of those eligible, how many received MAT during the reporting period?
A. Individuals eligible for MAT
B. Individuals receiving at least one treatment
Program Completion
16. Please enter the number of participants who successfully completed all requirements of
the jail/prison-based portion of your RSAT program during the reporting period. The number
entered should represent only those participants who successfully completed all the requirements of
the RSAT program during the reporting period.
A. Number of jail/prison-based successful completers
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID.FEIF2FC2-0500-4C5F-BDB7-207624628C21
17 Of those jail/prison-based participants who successfully completed all program
requirements. please enter the number who were released to the community during the
reporting period
A Number of jail/prison-based successful completers released to the community
B Of those reported in A how many individuals were released under correctional supervision
C Of the number of successful completers released to the community. how many individuals were
referred to an aftercare program Aftercare programs are defined in 42 U S.0 3796ff-l(c)
18 Of those jail/prison-based program completers released to the community please enter the
number with a continuity of care arrangement or reentry or transitional plan The
number should be based on the number of participants with active treatment plans that continue in
the community and on participants who receive referrals for services after their release into the
community
A Number of jail/prison-based successful completers with confirmed continuity of care
arrangements
19 Please enter the number of individuals who did not complete and are no longer
participants in the jail/prison-based portion of the RSAT program during the reporting
period Former participants should not fit rn more than one category so please choose the
option that best represents why these individuals did not complete the program
Jail/Prison-based!ncompletes
Measure Number
A Number of participants no longer in the program due to termination for a
new charge
B Number of participants no longer in the program due to release or transfer to
another correctional facility
C Number of participants no longer in the program due to death or serious
illness
D Number of participants no longer in the program due to voluntary drop out
E Number of participants no longer in the program due to failure to meet
program requirements
F Number of participants no longer in the program due to violation of
Institutional rules
G Number of participants who did not complete the program for other reasons
(Please specify)
Please specify
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No K4880-05
Docusign Envelope ID:FEIF2FC2-0500-4C5F-BDB7-207624628C21
20. Of those jail/prison-based participants who left the RSAT program successfully, please
enter the number who completed the program during the following timeframes:
A. 0-3 months
B 4-6 months
C 7-9 months
D 10 months or more_
21. Of those jail/prison-based participants who left the RSAT program unsuccessfully or did not
complete the program, please enter the number who left the program during the following
timeframes:
A. 0-3 months
B. 4-6 months
C 7-9 months
D 10 months or more
Alcohol and Substance Involvement
1. Please enter the number of jail/prison-based participants who were administered an
alcohol/drug test(e.g.. urinalysis test) before admission into your RSAT program. As a
requirement, grantees must agree to implement or continue to require urinalysis or other proven
reliable forms of testing, including both periodic and random testing(1) of an individual before the
individual enters an RSAT program and dunng the period in which the individual participates in the
treatment program,and(2) of an individual released from an RSAT program if the individual remains
in the custody of the state.
A. Number of jail/prison-based participants tested before admission
2 Of those enrolled in the jail/prison-based portion of the RSAT program, please enter the
total number of participants tested for alcohol or illegal substances during the reporting
period. This should represent the total number of RSAT participants who were given drug tests. The
number entered should be an unduplicated count only of participants who were tested for alcohol or
illegal substances, and it should be equal to or greater than the number of participants who tested
positive. If not, please check for data entry error.
A. Total number of jail/prison-based participants tested for alcohol or illegal substances
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FEIF2FC2-05004C5F-BD87-207624628C21
3 Of those enrolled in the jail/prison-based portion of the RSAT program, please enter the
number of participants who tested positive for the presence of alcohol or illegal substances
during the reporting period The number entered should be an unduplicated count only of
participants who tested positive for alcohol or illegal substances. and it should be equal to or less
than the total number of participants tested If not, please check for data entry error Alcohol and
substance use information should be based on documented tests rather than self-reported
information from program participants. Include all participants who received services during the
reporting period, regardless of whether they successfully completed the RSA program, left without
completing it. or are currently enrolled
A Number of jail/prison-basedparticipants who tested positive for alcohol or illegal
substances
4 During the reporting period please enter the number of participants who were administered
an alcohol/drug test (e g . urinalysis test) within 30 days after successfully completing
your residential drug treatment program and are still under supervision of the program
A Number of jail/prison-based participants tested after program completion
B Of that number. how many tested positive for alcohol or illegal substances after program
completion
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No K4880-05
Docusign Envelope ID FE 1 F2FC2-0500-4C5F-BDB7-207624628C21
. . • 011: ' 1
The next set of auestions is about court and criminal involvement for offenders who have ever
participated in the RSAT Jail/prison-based program. This section is to be completed at the close of
the grant.
5 Since the start of the BJA RSAT award, how many jail/prison-based participants
A Are still participating in the jai I/pri son-based RSAT program?
B Have successfully completed the jail/prison-based RSAT program and released into the
community?
C Did not complete the)ail/prison-based RSAT program and released into the community'?
D Were released into a mandated aftercare program Aftercare programs are defined In 42 U S C
3796N-l(c)
6 Since the start of the RSAT BJA award, enter the total number of jail/prison-based
participants released into the community who successfully completed and unsuccessfully
exited and were reincarcerated
ReceivedCourt and Criminal Involvement Since the Start of the BJA Award for
.ndividuals Who Aftercare Services
Reincarcerated Reincarcerated
based on a New based on a
Measure Criminal Revocation for a
Charge Technical
Violation
Participants released into the community (excluding
A mandated aftercare programs)who successfully
completed the)ail/prison based program
Participants released into the community (excluding
B mandated aftercare programs)who participated but
unsuccessfully exited the program
!SEMIANNUALARRA QUESTIONS
Please answer the following questions every semiannual reporting period (January and July of
each year). based on your grant-funded activities.
1 What were your accomplishments during reporting period?
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No K4880-05
Docusign Envelope ID:FEIF2FC2-0500-4C5F-BDB7-207624628C21
2. What goals were accomplished, as they relate to your grant application?
3. What problems/barriers did you encounter, if any, within the reporting period that prevented you from
reaching your goals or milestones?
4. Is there any assistance that BJA can provide to address any problems/barriers identified in question#3?
(Please answer Yes or No. If No, please explain)
A. Yes/No
B. If Yes, please explain
5. Are you on track to fiscally and programmatically complete your program as outlined in your grant
application? (Please answer Yes or No. If No, please explain.)
A. Yes/No
B. If No, please explain
6. What major activities are planned for the next 6 months?
7. Based on your knowledge of the criminal justice field, are there any innovative
programs/accomplishments that you would like to share with BJA?
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BDB7-207624628C21
ATTACHMENT 8
Standards of Care for Opioid Use Disorder
Purpose.
To provide evidence-based substance use treatment to participants in the RSAT program both
in custody and in the community who are identified with a substance use disorder Standard of
care for participants with oploid use disorder (OUD) and alcohol use disorder (AUD) must
include a full medications for oploid use disorder (MOUD) and medications for alcohol use
disorder (MAUD) program with the following elements an OUD/AUD screening. discussion of
MOUD/MAUD options between the incarcerated individual and provider, initiation prior to the
onset of withdrawal or continuation of MOUD/MAUD. release and reentry planning to include
connection with continued treatment. same day release appointment when possible or
MOUD/MAUD to bridge patient until next appointment and naloxone upon release Reentry
planning may also include assisting the incarcerated individual with sign-up of Medicaid.
reestablishing Medicaid and connection with the Managed Care Organizations (MCOs)
Health Equity - This project also intends to address inequities in SUD treatment and recovery
services by providing medically necessary treatment for SUD to incarcerated individuals The
RSAT program should understand cultural barriers and provide culturally appropriate services
and recognize the need for inclusion of people with lived experiences in the development of the
RSAT programs Additionally, this project intends to identify stigma and educate staff to ensure
ongoing collaboration and openness to change
The Contractor shall ensure funds are responsibly used towards the)ail or prison based RSAT
Program and provide the standard of care core components which include
1.1 General Standards.
1 1.1. 2020 ASAM National Practice Guideline for the Treatment of Opioid Use Disorder.
1.1.2. Guidelines for Managing Substance Withdrawal in Jails;
1.1.3. For AI/AN program participant receiving MOUD/MAUD Services, the Contractor's Tribal
Liaison, or designee. shall coordinate with the program participant's Indian Health Care Provider
(IHCP) to ensure the IHCP can participate in treatment and discharge planning including
continuity of care in the nearest IHCP clinically appropriate setting for all AI/AN program
participant.
2.2. Intake.
2 2 1 Continue MOUD and MAUD for individuals who are already taking these medications
upon entering the facility
2.2.2. Continue the individual on the same medication at the same dose unless ordered
otherwise by the prescriber based on clinical need (documented in the individual's medical
record) with the exceptions listed below
2.2 2.1 Injectable long-acting naltrexone may be converted to an equivalent oral dose until just
prior to release at which time the injectable form shall be restarted.
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BDB7-207624628C21
2.2.2.2. Injectable long-acting buprenorphine may be converted to an equivalent oral dose until
just prior to release at which time the injectable form shall be restarted.
2.2.2.3. Oral buprenorphine may be converted among the three formulations (film, tablet with
naloxone, tablet without naloxone).
2.2.2.4. If the individual is not pregnant, methadone may be transitioned to buprenorphine if the
jail is not a licensed Opioid Treatment Program (OTP) and the nearest OTP is not within
reasonable driving distance from the jail or there is no OTP within reasonable distance of the
individual's release residence.
2.2.2.5. Though MOUD/MAUD may not be discontinued on a policy or administrative basis
because of the presence of other illicit or controlled substances, administration of the
community-based MOUD or MAUD may be adjusted if clinically necessary due to
pharmacologic risks of drug-drug interaction.
2.2.3. Screen all newly admitted individuals for risk of acute withdrawal from opioids and alcohol
upon intake.
2.2.4. Screen for OUD and AUD without physical dependence (i.e. without a risk of acute
withdrawal) after intake, as long as the delay does not impair the ability to begin treatment prior
to release.
2.2.5. Offer initiation of MOUD treatment to individuals who are physically dependent on opioids.
2.2.6. Educate individuals on treatment choices and the process for continuation of access to
MOUD, during incarceration, and upon release.
2.2.7. Make available and offer treatment using some formulation of methadone, buprenorphine.
and naltrexone based on a mutually agreed-upon plan between the prescriber and the
individual, with the following exceptions or caveats:
2.2.7.1. The jail may decline to offer methadone if the jail is not a licensed OTP, and the nearest
OTP is not within reasonable driving distance from the jail or there is no OTP within reasonable
distance of the individual's release residence.
2.2.7.2. If there is no available buprenorphine provider in the community to which the individual
will release, the Jail must still offer buprenorphine (tapered over several days) if opioid
withdrawal is clinically indicated.
2.2.7.3. If withdrawal is not clinically indicated and the only reason for considering
discontinuation of buprenorphine is the lack of an available buprenorphine provider in the
community to which the individual will release, a decision whether or not—or when —to
discontinue buprenorphine prior to release should be made based on a plan mutually agreed -
upon between the individual and the prescriber based on the length of time the individual is
expected to remain in the jail.. the risks of opioid misuse or overdose during the incarceration,
and the individual's willingness to receive a dose of an extended release injectable
buprenorphine just prior to release that will provide the individual a safe tapered withdrawal in
the community if no provider is available.
2.2.7.4. Provide naltrexone in oral formulation while the individual is incarcerated. Offer
injectable long-acting naltrexone or buprenorphine as an option prior to release.
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FE1 F2FC2-0500-4C5F-BDB7-207624626C21
2.2.7.5. Offer oral buprenorphine without naloxone while the individual is incarcerated but must
discharge the individual on a formulation of buprenorphine with naloxone unless there is a
clinical reason not to do so (e.g.. the individual is discharged on injectable buprenorphine, the
individual is allergic to naloxone).
2.2.8. Contractor shall not facilitate forced opioid withdrawal (including withdrawal using a
tapering dose of buprenorphine or methadone) unless the individual provides an informed
refusal of treatment or the individual elects MOUD treatment with naltrexone, in which case
withdrawal is clinically required.
2.2.8.1. In such case, Contractor may use other medications (clonidine. anti-emetics, anti-
diarrheals, analgesics) in place of buprenorphine or methadone if the individual so chooses or
as adjuncts to these medications, but they may not be the only withdrawal treatment available.
2.2.8.2. Initiation of buprenorphine or methadone, whether for induction of treatment or for
withdrawal, may not be delayed for administrative reasons, e.g., unavailability of a prescriber,
beyond when they are clinically indicated to be started.
2.2.9. Offer treatment for withdrawal with benzodiazepines to individuals entering the facility
who are physically dependent on alcohol, if clinically appropriate.
2.2.10. Provide immediate evaluation to individuals at risk for, or in, opioid or alcohol withdrawal
who refuse treatment by a medical or mental health prescriber or a licensed mental health
professional at the masters' level or higher, to determine if they have decision-making capacity.
If they do not, they must be transported to a community hospital and may not return to the jail
until they are clinically safe to return to the jails AND have regained decision-making capacity.
2.3. During Incarceration.
2.3.1. Offer initiation of MOUD/MAUD to individuals with OUD/AUD not already identified and/or
offered treatment at intake(e.g., individuals with OUD but without physical dependence;
individuals with AUD who underwent withdrawal).
2.3.2. Educate individuals on treatment choices and the process for continuation of access to
MOUD/MAUD, during incarceration, and upon release.
2.3.3. Administer methadone and buprenorphine daily or more frequently.
2.3.4. Contractor will not use alternate-day ("Balloon")dosing of buprenorphine.
2.3.5. Offer counseling to individuals for their OUD and/or AUD disorder who are expected to
remain in jail for longer than one month.
2.3.6. Provide MOUD/MAUD not contingent on the individual's willingness to participate in
counseling.
2.4. Release.
The Jail must accomplish the following prior to release: 3.4.1. Complete release planning and
reentry coordination as soon as possible after admission to ensure an effective plan is in place
prior to release or in the event of an unexpected release of an individual who needs continued
treatment and services.
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID:FE1 F2FC2-0500-4C5F-BDB7-207624628C21
2.4.2. Provide at least two (2) doses of naloxone (e.g., Narcan®) or nalmefene (Opvee®) and
training on how to administer the medications to all individuals with OUD.
2.4.3. Schedule the first community appointment with a treatment facility for continuation of
MOUD or MAUD.
2.4.5. Provide-in hand, upon release, and at no cost to the individual-sufficient doses of MOUD
and/or MAUD to bridge individual until scheduled MOUD/MAUD follow-up appointment at
community treatment facility (does not apply to individuals treated with injectable
MOUD/MAUD).
2.4.5.1. Inform individuals who are at risk of being released directly from court, prior to going to
court, that they may request to be transported back to the jail by staff to receive these
medications prior to going home.
2.4.5.2. In situations where an appointment cannot be made, e.g., after-hours bail-out, give the
individual enough medication to last until the next available appointment at the community
treatment facility. If the appointment date is unknown, give individual a minimum of a30-day
supply.
2.4.5.3. In situations where medications cannot be provided upon release. e.g.. unscheduled
release at a time when medical staff are not present in the jail:
2.4.5.3.1. Inform the individual that they may either return to the jail in the morning to receive
bridge medications, or
2.4.5.3.2. If no medical staff are present the following day, call in a prescription for the same
bridging medication to a local pharmacy, at no cost to the individual.
2.4.6. Assist Medicaid-eligible individuals to sign-up with Medicaid or assist individuals whose
Medicaid coverage has been terminated to reestablish coverage.
2.4.7. For any individual with Medicaid coverage, work cooperatively with the individual's
Managed Care Organizations (MCO)to facilitate re-entry, including but not limited to allowing
the MCO's agent timely access to the facility and the individual.
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BDB7-207624628C21
ATTACHMENT 9
Department of Justice (DOJ)
Office of Justice Programs
Bureau of Justice Assistance
Terms
As identified in the Federal Subaward Identification attachment/s, this Contract includes funds HCA
received through a grant from the Department of Justice(DOJ). HCA and the Contractor intend that this
Contract conforms with the requirements of the DOJ grant (award). Contractor agrees to comply with
the following pass-through terms, in addition to the terms and conditions of the Contract,for contract
activities funded by the DOJ grant.
Failure to comply with one or more grant requirements -- whether a condition set out in full below, a
condition incorporated by reference below,or an assurance or certification related to conduct during the
award period -- may result in HCA taking appropriate action with respect to the Contractor and the
Contract. Among other things, HCA may withhold funds, disallow costs, or suspend or terminate the
Contract. HCA may take other legal action as appropriate.
Any materially false,fictitious,or fraudulent statement to HCA or the federal government related to this
Contract (or concealment or omission of a material fact) may be the subject of criminal prosecution
(including under 18 U.S.C. 1001 and/or 1621, and/or 34 U.S.C. 10271-10273), and also may lead to
imposition of civil penalties and administrative remedies for false claims or otherwise(including under 31
U.S.C. 3729-3730 and 3801-3812).
If any provision of a requirement of the DOJ grant is held to be invalid or unenforceable by its terms,that
provision shall first be applied with a limited construction to give it the maximum effect permitted by law.
Should it be held, instead,that the provision is utterly invalid or-unenforceable, such provision shall be
deemed severable from this Contract.
1. Requirements of the award;remedies for non-compliance or for materially false statements
The conditions of the grant/s identified in the Contract FSI/s are material requirements of the
Contract. Compliance with any assurances or certifications submitted by or on behalf of the
Contractor that relate to conduct during the period of performance also is a material requirement of
this Contract.
2. Limited Exceptions
In certain special circumstances,the U.S. Department of Justice(DOJ)may determine that it will not
enforce, or enforce only in part,one or more requirements otherwise applicable to the award. Any
such exceptions regarding enforcement, including any such exceptions made during the period of
performance,are(or will be during the period of performance)set out through the Office of Justice
Programs (OJP) webpage entitled "Legal Notices: Special circumstances as to particular award
conditions" (ojp.gov/funding/Explore/LegalNotices-AwardRegts.htm), and incorporated by
reference into the award received by HCA and passed to the Contractor.
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FE 1 F2FC2-0500-4C5F-BDB7-207624628C21
3. Applicability of Part 200 Uniform Requirements
The Uniform Administrative Requirements,Cost Principles, and Audit Requirements in 2 C.F.R. Part
200, as adopted and supplemented by DOJ in 2 C.F.R. Part 2800(together,the"Part 200 Uniform
Requirements")apply to this Contract.
For more information and resources on the Part 200 Uniform Requirements as they relate to OJP
awards and subawards("subgrants"),see the OJP website at
https://ojp.gov/funding/Part200UniformRequirements.htm.
4. Record retention and access
Records pertinent to the Contract that the Contractor must retain -- and to which the Contractor
must provide access, include performance measurement information, in addition to the financial
records,supporting documents,statistical records,and other pertinent records indicated at 2 C.F.R.
200.333.
5. Compliance with DOJ Grants Financial Guide
Contractor agrees to comply with the DOJ Grants Financial Guide as posted on the OJP website
(currently,the"DOJ Grants Financial Guide" available at
https://ojp.gov/financialguide/DOJ/index.htm), including any updated version that may be posted
during the period of performance.
6. Requirement to report potentially duplicative funding
If the Contractor currently has other active awards or subawards of federal funds,or if the
Contractor receives any other award of federal funds during the period of performance for this
Contract,the Contractor promptly must determine whether funds from any of those other federal
awards have been, are being,or are to be used(in whole or in part)for one or more of the
identical cost items for which funds are provided under this Contract. If so,the Contractor must
promptly notify the HCA Contract Manager in writing of the potential duplication. HCA may
require a budget-modification or change-of-project-scope grant adjustment notice(GAN)to
eliminate any inappropriate duplication of funding.
7. Employment eligibility verification for hiring under the Contract
a. The Contractor and any subrecipient at any tier must—
i. Ensure that,as part of the hiring process for any position within the United States
that is or will be funded(in whole or in part)with Contract funds, the Contractor
(or any subrecipient) properly verifies the employment eligibility of the individual
who is being hired,consistent with the provisions of 8 U.S.C. 1324a(a)(1)and (2).
ii. Notify all persons associated with the Contractor(or any subrecipient)who are or
will be involved in activities under this Contract of both--
1. this requirement for verification of employment eligibility, and
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BDB7-207624628C21
2. the associated provisions in 8 U.S.C. 1324a(a)(1)and (2)that,generally
speaking, make it unlawful, in the United States,to hire(or recruit for
employment)certain aliens.
iii. Provide training(to the extent necessary)to those persons required by this
condition to be notified of the requirement for employment eligibility verification
and of the associated provisions of 8 U.S.C. 1324a(a)(1)and (2).
iv. As part of the recordkeeping for the Contract(including pursuant to the Part 200
Uniform Requirements), maintain records of all employment eligibility
verifications pertinent to compliance with this award condition in accordance
with Form 1-9 record retention requirements, as well as records of all pertinent
notifications and trainings.
b. Monitoring
Contractor will cooperate with HCA's monitoring responsibilities of Contractor's
compliance with this condition.
c. Allowable costs
To the extent that such costs are not reimbursed under any other federal program,
Contract funds may be obligated for the reasonable, necessary,and allocable costs(if any)
of actions designed to ensure compliance with this condition.
d. Rules of construction
i. Staff involved in the hiring process
For purposes of this condition, persons"who are or will be involved in
activities under this Contract"specifically includes(without limitation)any
and all Contractor(or any subrecipient)officials or other staff who are or will
be involved in the hiring process with respect to a position that is or will be
funded(in whole or in part)with Contract funds.
ii. Employment eligibility confirmation with E-Verify
For purposes of satisfying the requirement of this condition regarding
verification of employment eligibility,the Contractor(or any subrecipient)
may choose to participate in, and use, E-Verify(www.e-verify.gov),
provided an appropriate person authorized to act on behalf of the
Contractor(or subrecipient) uses E-Verify(and follows the proper E-Verify
procedures, including in the event of a "Tentative Nonconfirmation"or a
"Final Nonconfirmation")to confirm employment eligibility for each hiring
for a position in the United States that is or will be funded(in whole or in
part)with Contract funds.
iii. "United States"specifically includes the District of Columbia, Puerto Rico,Guam,
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID:FEIF2FC2-0500-4C5F-BOB7-207624628C21
the Virgin Islands of the United States, and the Commonwealth of the Northern
Mariana Islands.
e. Nothing in this condition shall be understood to authorize or require the Contractor, any
subrecipient at any tier,or any person or other entity,to violate any federal law,including any
applicable civil rights or nondiscrimination law.
f. Nothing in this condition shall be understood to relieve the Contractor,any subrecipient at any
tier,or any person or other entity,of any obligation otherwise imposed by law,including 8
U.S.C. 1324a(a)(1)and(2).
Questions about E-Verify should be directed to DHS. For more information about E-Verify visit
the E-Verify website https://www.e-verify.pov/)or email E-Verify at E-Verify@dhs.gov.E-Verify
employer agents can email E-Verify at E-VerifyEmpioverAgent@dhs.gov.
8. Requirement to report actual or imminent breach of personally identifiable information (Pill
The Contractor(and any"subrecipient" at any tier) must have written procedures in place to
respond in the event of an actual or imminent "breach'' (OMB M-17-12) if it (or a subrecipient) --
(1) creates, collects, uses, processes, stores, maintains,disseminates,discloses,or disposes of
"personally identifiable information (PII)" (2 CFR 200.79)within the scope of an OJP grant-funded
program or activity, or(2) uses or operates a "Federal information system" (OMB Circular A-130).
The Contractor's breach procedures must include a requirement to report actual or imminent
breach of PII to HCA as identified in the Contract no later than 24 hours after an occurrence of an
actual breach, or the detection of an imminent breach.
9. Approval required to use a noncompetitive approach in any procurement contract that would
exceed $250,000
Contractor will notify the HCA Contract Manager of any procurement contract funded by this
Contract that may exceed $250,000. The Contractor, and any subrecipient ("subgrantee") at any
tier, must comply with all applicable requirements to obtain specific advance approval to use a
noncompetitive approach in any procurement contract that would exceed the Simplified
Acquisition Threshold (currently, $250,000). This condition applies to agreements that --for
purposes of federal grants administrative requirements--OJP considers a procurement "contract"
(and therefore does not consider a subaward).
The details of the requirement for advance approval to use a noncompetitive approach in a
procurement contract under an OJP award are posted on the OJP web site at
https://ojp.gov/funding/Explore/NoncompetitiveProcurement.htm (Award condition: Specific
post-award approval required to use a noncompetitive approach in a procurement contract (if
contract would exceed$250,000))and are incorporated by reference here.
10. Unreasonable restrictions on competition under the award;association with federal government
SCOPE. This condition applies with respect to any procurement of property or services that
is funded (in whole or in part) by this Contract, whether by the Contractor or by any
subrecipient at any tier, and regardless of the dollar amount of the purchase or acquisition,
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No K4880-05
Docusign Envelope ID FEIF2FC2-05004C5F-BDB7-207624628C21
the method of procurement, or the nature of any legal instrument used. The provisions of
this condition must be among those included in any subaward (at any tier).
a. No discrimination, in procurement transactions, against associates of the federal
government
Consistent with the(DOJ) Part 200 Uniform Requirements -- including as set out at 2 C.F.R.
200.300(requiring awards to be "manage(d]and administer[ed] in a manner so as to
ensure that Federal funding is expended and associated programs are implemented in full
accordance with U.S. statutory and public policy requirements")and 200.319(a) (generally
requiring"[a]II procurement transactions [to] be conducted in a manner providing full and
open competition"and forbidding practices "restrictive of competition,"such as"[p]lacing
unreasonable requirements on firms in order for them to qualify to do business" and taking
"[a]ny arbitrary action in the procurement process")—the Contractor(or subrecipient,at
any tier)may not(in any procurement transaction)discriminate against any person or entity
on the basis of such person or entity's status as an "associate of the federal government"
(or on the basis of such person or entity's status as a parent, affiliate,or subsidiary of such
an associate),except as expressly set out in 2 C.F.R.
200.319(a)or as specifically authorized by US DOJ.
b. Monitoring
Contractor will cooperate with HCA to fulfill HCA's responsibility to monitor Contractor's
compliance with this condition.
c. Allowable costs
To the extent that such costs are not reimbursed under any other federal program,
Contract funds may be obligated for the reasonable, necessary,and allocable costs(if any)
of actions designed to ensure compliance with this condition.
d. Rules of construction
i. The term "associate of the federal government" means any person or entity
engaged or employed(in the past or at present) by or on behalf of the federal
government --as an employee, contractor or subcontractor(at any tier),grant
recipient or-subrecipient(at any tier), agent,or otherwise--in undertaking any
work, project, or activity for or on behalf of(or in providing goods or services to
or on behalf of)the federal government, and includes any applicant for such
employment or engagement,and any person or entity committed by legal
instrument to undertake any such work, project,or activity(or to provide such
goods or services) in future.
ii. Nothing in this condition shall be understood to authorize or require the
Contractor,any subrecipient at any tier,or any person or other entity,to violate
any federal law, including any applicable civil rights or nondiscrimination law.
11. Requirements pertaining to prohibited conduct related to trafficking in persons(including
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FE1F2FC2-0500-4C5F-BDB7-207624628C21
reporting requirements and HCA's authority to terminate award)
The Contractor,and any subrecipient("subgrantee")at any tier, must comply with all applicable
requirements(including requirements to report allegations) pertaining to prohibited conduct
related to the trafficking of persons,whether on the part of Contractor,subrecipients
("subgrantees"),or individuals defined(for purposes of this condition)as "employees" of the
Contractor or of any subrecipient.
The details of the Contractor's obligations related to prohibited conduct related to trafficking in
persons are posted on the OJP web site at https://ojp.gov/funding/Explore/ProhibitedConduct-
Trafficking.htm
Prohibited conduct by Contractor and subrecipients related to trafficking in persons(including
reporting requirements and HCA's authority to terminate award))and are incorporated by
reference here.
12. Determination of suitability to interact with participating minors
This condition applies to this Contract if it is indicated--in the application for the award (as
approved by DOJ)(or in the application for any subaward, at any tier),the DOJ funding
announcement(solicitation),or an associated federal statute--that a purpose of some or all of
the activities to be carried out under the Contract(whether by the Contractor,or a subrecipient at
any tier) is to benefit a set of individuals under 18 years of age.
The Contractor, and any subrecipient at any tier, must make determinations of suitability before
certain individuals may interact with participating minors.This requirement applies regardless of
an individual's employment status.
The details of this requirement are posted on the OJP web site at
https://ojp.gov/funding/Explore/Interact-Minors.htm(Award condition:Determination of
suitability required, in advance,for certain individuals who may interact with participating
minors),and are incorporated by reference here.
13. Compliance with applicable rules regarding approval, planning,and reporting of conferences,
meetings,trainings,and other events
The Contractor,and any subrecipient("subgrantee")at any tier, must comply with all
applicable laws, regulations, policies,and official DO1 guidance(including specific cost limits,
prior approval and reporting requirements,where applicable)governing the use of federal
funds for expenses related to conferences(as that term is defined by DO1), including the
provision of food and/or beverages at such conferences, and costs of attendance at such
conferences.
Information on the pertinent DO1 definition of conferences and the rules applicable to this
Contract appears in the DOJ Grants Financial Guide(currently,as section 3.10 of"Postaward
Requirements" in the"DOJ Grants Financial Guide").
14. Requirement for data on performance and effectiveness
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID.FEIF2FC2-0500-4C5F-BD67-207624628C21
The Contractor must collect and maintain data that measure the performance and
effectiveness of work as identified in this Contract.The data must be provided to HCA in the
manner(including within the timeframes)specified by HCA in this Contract,the solicitation or
other applicable written guidance. Data collection supports compliance with the
Government Performance and Results Act (GPRA)and the GPRA Modernization Act of 2010,
and other applicable laws.
15. OJP Training Guiding Principles
Any training or training materials that the Contractor--or any subrecipient("subgrantee")at any
tier--develops or delivers with OJP award funds must adhere to the CJP Training Guiding
Principles for Grantees and Subgrantees,available at
https://ojp.gov/funding/Implement/TrainingPrinciplesForGrantees-Subgrantees.htm.
16. Effect of failure to address audit issues
The Contractor understands and agrees that HCA may withhold Contract funds, or may impose
other related requirements, if(as determined by HCA)the Contractor does not satisfactorily and
promptly address outstanding issues from audits required by the Part 200 Uniform Requirements
(or by the terms of this Contract),or other outstanding issues that arise in connection with audits,
investigations,or reviews of DOJ awards.
17. Potential imposition of additional requirements
The Contractor agrees to comply with any additional requirements that may be imposed by
HCA during the period of performance for this Contract, if the Contractor is designated as
"high-risk"for purposes of the DOJ high-risk grantee list.
18. Compliance with DOJ regulations pertaining to civil rights and nondiscrimination -28 C.F.R. Part 42
The Contractor,and any subrecipient("subgrantee") at any tier, must comply with all applicable
requirements of 28 C.F.R. Part 42,specifically including any applicable requirements in Subpart E of
28 C.F.R. Part 42 that relate to an equal employment opportunity program.
19. Compliance with DOJ regulations pertaining to civil rights and nondiscrimination -28 C.F.R. Part 54
The Contractor,and any subrecipient("subgrantee")at any tier, must comply with all applicable
requirements of 28 C.F.R. Part S4,which relates to nondiscrimination on the basis of sex in certain
"education programs."
20. Compliance with DOJ regulations pertaining to civil rights and nondiscrimination-28 C.F.R. Part 38
The Contractor, and any subrecipient("subgrantee")at any tier,must comply with all applicable
requirements of 28 C.F.R.Part 38(as may be applicable from time to time),specifically including
any applicable requirements regarding written notice to program beneficiaries and prospective
program beneficiaries.
Currently,among other things, 28 C.F.R. Part 38 includes rules that prohibit specific forms of
discrimination on the basis of religion, a religious belief, a refusal to hold a religious belief, or
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID.FE1F2FC2-0500-4C5F-BDB7-207624628C21
refusal to attend or participate in a religious practice. Part 38, currently,also sets out rules and
requirements that pertain to the Contractor and subrecipient("subgrantee")organizations that
engage in or conduct explicitly religious activities, as well as rules and requirements that pertain
to recipients and subrecipients that are faith-based or religious organizations.
The text of 28 C.F.R. Part 38 is available via the Electronic Code of Federal Regulations (currently
accessible at https://www.ecfr.gov/cgi-bin/ECFR?page=browse),by browsing to Title 28-Judicial
Administration,Chapter 1,Part 38, under a-CFR"current"data.
21. Restrictions on "lobbying"
In general,as a matter of federal law,federal funds awarded by OJP may not be used by the
Contractor,or any subrecipient ("subgrantee")at any tier, either directly or indirectly,to support
or oppose the enactment, repeal, modification,or adoption of any law, regulation,or policy,at
any level of government.See 18 U.S.C. 1913. (There may be exceptions if an applicable federal
statute specifically authorizes certain activities that otherwise would be barred by law.)
Another federal law generally prohibits federal funds awarded by OJP from being used by the
Contractor,or any subrecipient at any tier,to pay any person to influence(or attempt to influence)
a federal agency, a Member of Congress,or Congress(or an official or employee of any of them)
with respect to the awarding of a federal grant or cooperative agreement,subgrant,contract,
subcontract,or loan,or with respect to actions such as renewing,extending,or modifying any
such award. See 31 U.S.C. 1352. Certain exceptions to this law apply, including an exception that
applies to Indian tribes and tribal organizations.
22. Compliance with general appropriations-law restrictions on the use of federal funds
The Contractor, and any subrecipient("subgrantee")at any tier, must comply with all applicable
restrictions on the use of federal funds set out in federal appropriations statutes. Pertinent
restrictions that may be set out in applicable appropriations acts are incorporated by reference
here.Should a question arise as to whether a particular use of federal funds by the Contractor(or
a subrecipient)would or might fall within the scope of an appropriations-law restriction,the
Contractor is to ask the HCA Contract Manager for guidance and may not proceed without the
express prior written approval of the HCA Contract Manager.
23. Reporting potential fraud,waste, and abuse,and similar misconduct
The Contractor, and any subrecipients ("subgrantees") at any tier, must promptly refer to HCA as
required by the Contract,and the DOJ Office of the Inspector General (OIG)any credible evidence
that a principal,employee,agent,subrecipient,contractor,subcontractor,or other person has, in
connection with funds under this award--(1)submitted a claim that violates the False Claims Act;
or(2)committed a criminal or civil violation of laws pertaining to fraud,conflict of interest,
bribery,gratuity,or similar misconduct.
Potential fraud,waste,abuse,or misconduct involving or relating to funds under this Contract
should be reported to HCA as required by the Contract and the OIG by--(1)online submission
accessible via the OIG webpage at https://oig.justice.gov/hotline/contact-grants.htm (select
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BDB7-207624628C21
"Submit Report Online"); (2) mail directed to: U.S. Department of Justice,Office of the Inspector
General, Investigations Division,ATTN: Grantee Reporting,950 Pennsylvania Ave., NW,
Washington, DC 20530; and/or(3) by facsimile directed to the DOJ OIG Investigations Division
(Attn:Grantee Reporting)at (202)616-9881(fax).
Additional information is available from the DOJ OIG website at https://oig.justice.gov/hotline.
24. Restrictions and certifications regarding non-disclosure agreements and related matters
Neither the Contractor nor a subrecipient("subgrantee") under this Contract,or entity that
receives a procurement contract or subcontract with any funds under this Contract, may require
any employee or contractor to sign an internal confidentiality agreement or statement that
prohibits or otherwise restricts,or purports to prohibit or restrict,the reporting(in accordance
with law)of waste, fraud,or abuse to an investigative or law enforcement representative of a
federal department or agency authorized to receive such information.
The foregoing is not intended, and shall not be understood to contravene requirements applicable
to Standard Form 312(which relates to classified information), Form 4414 (which relates to
sensitive compartmented information),or any other form issued by a federal department or
agency governing the nondisclosure of classified information.
a. In accepting this Contract,the Contractor—
i. represents that it neither requires nor has required internal confidentiality
agreements or statements from employees or contractors that currently prohibit
or otherwise currently restrict(or purport to prohibit or restrict)employees or
contractors from reporting waste,fraud, or abuse as described above; and
ii. certifies that,if it learns or is notified that it is or has been requiring its employees
or contractors to execute agreements or statements that prohibit or otherwise
restrict (or purport to prohibit or restrict), reporting of waste,fraud,or abuse as
described above, it will immediately stop any further obligations of Contract
funds,will provide prompt written notification to the HCA Contract Manager,and
will resume(or permit resumption of)such obligations only if expressly
authorized to do so by them.
b. If the Contractor does or is authorized under this Contract to make subawards
("subgrants"), procurement contracts, or both-- it represents that--
i. it has determined that no other entity that may or will receive Contract
funds(whether through a subaward ("subgrant"), procurement contract,or
subcontract under a procurement contract)either requires or has required
internal confidentiality agreements or statements from employees or
contractors that currently prohibit or otherwise currently restrict(or purport
to prohibit or restrict)employees or contractors from reporting waste,fraud,
or abuse as described above; and
ii. it has made appropriate inquiry, or otherwise has an adequate factual basis,to
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FEIF2FC2-05004C5F-BDB7-207624628C21
support this representation;and
iii. it certifies that, if it learns or is notified that any subrecipient,contractor,or
subcontractor entity that receives funds under this Contract is or has been
requiring its employees or contractors to execute agreements or statements that
prohibit or otherwise restrict(or purport to prohibit or restrict), reporting of waste,
fraud, or abuse as described above, it will immediately stop any further obligations
of Contract funds to or by that entity,will provide prompt written notification to
the HCA Contract Manager,and will resume(or permit resumption of)such
obligations only if expressly authorized to do so by them.
25. Compliance with 41 U.S.C.4712(including prohibitions on reprisal; notice to employees)
The Contractor(and any subrecipient at any tier) must comply with,and is subject to,all
applicable provisions of 41 U.S.C.4712, including all applicable provisions that prohibit,under
specified circumstances,discrimination against an employee as reprisal for the employee's
disclosure of information related to gross mismanagement of a federal grant, a gross waste of
federal funds, an abuse of authority relating to a federal grant, a substantial and specific danger to
public health or safety,or a violation of law, rule,or regulation related to a federal grant.
The Contractor also must inform its employees, in writing(and in the predominant native
language of the workforce),of employee rights and remedies under 41 U.S.C.4712.
26. Encouragement of policies to ban text messaging while driving
Pursuant to Executive Order 13513, "Federal Leadership on Reducing Text Messaging While
Driving," 74 Fed. Reg. 51225 (October 1, 2009), DOJ encourages recipients and subrecipients
("subgrantees")to adopt and enforce policies banning employees from text messaging while
driving any vehicle during the course of performing work funded by this award,and to establish
workplace safety policies and conduct education,awareness,and other outreach to decrease
crashes caused by distracted drivers.
27. Requirement to disclose whether Contractor is designated "high risk" by a federal grant-making
agency outside of DOJ
If the Contractor is designated "high risk" by a federal grant-making agency outside of DOJ,
currently or at any time during the period of performance the Contract,the Contractor must
disclose that fact and certain related information in writing to the HCA Contract Manager. For
purposes of this disclosure, high risk includes any status under which a federal awarding agency
provides additional oversight due to the Contractor's past performance,or other programmatic or
financial concerns with the Contractor.
The Contractor's disclosure must include the following:
a. The federal awarding agency that currently designates the Contractor high risk.
b. The date the Contractor was designated high risk.
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BD87-207624628C21
c. The high-risk point of contact at that federal awarding agency(name, phone number,and
email address).
d. The reasons for the high-risk status, as set out by the federal awarding agency.
28. The Contractor agrees that federal funds under this Contract will be used to supplement but not
supplant state or local government funds.
29. The State/Territory(State)will coordinate the design and implementation of treatment programs
between State correctional representatives and the State alcohol and drug abuse agency(and, if
appropriate, between representatives of local correctional agencies and representatives of either
the State alcohol and drug abuse agency or any appropriate local alcohol and drug abuse agency,
especially where there is opportunity to coordinate with initiatives funded through the Justice
Assistance Grant(JAG) program).
30.The Contractor agrees that grant funds may be used to pay for data collection,analysis,and
report preparation only if that activity is associated with federal reporting requirements. Other
data collection,analysis, and evaluation activities are not allowable uses of grant funds.
31. The State/Territory(State)will implement or continue to require urinalysis or other proven
reliable forms of testing of individuals in correctional residential substance abuse treatment
programs.Such testing shall include individuals released from residential substance abuse
treatment programs who remain in the custody of the State.
32.The Contractor agrees that Contract funds may be used to pay for data collection,analysis,and
report preparation only if that activity is associated with federal reporting requirements. Other
data collection,analysis, and evaluation activities are not allowable uses of Contract funds.
33. Use of program income
Program income(as defined in the Part 200 Uniform Requirements) must be used in accordance
with the provisions of the Part 200 Uniform Requirements. Program income earnings and
expenditures both must be reported on the quarterly Federal Financial Report,SF 425.
34. Cash compensation
With respect to this Contract,federal funds may not be used to pay cash compensation (salary plus
bonuses)to any employee of the Contractor at a rate that exceeds 110%of the maximum annual
salary payable to a member of the federal government's Senior Executive Service(SES)at an agency
with a Certified SES Performance Appraisal System for that year. (Contractor may compensate an
employee at a higher rate,provided the amount in excess of this compensation limitation is paid
with non-federal funds.)
This limitation on compensation rates allowable under this Contract may be waived on an
individual basis at the discretion of the HCA Contract Manager.
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BDB7-207624628C21
35. The Contractor agrees to submit to the HCA Contract Manager for review and approval any
curricula,training materials, proposed publications, reports,or any other written materials that will
be published, including web-based materials and web site content,through funds from this
Contract at least sixty(60)working days prior to the targeted dissemination date. Any written,
visual,or audio publications,with the exception of press releases,whether published at the
Contractor's or government's expense, shall contain the following statements:
"This project was supported by Grant No(s). 15PBJA-22-GG-00502& 15PBJA-23-GG-01570
awarded by the Bureau of Justice Assistance.The Bureau of Justice Assistance is a component of
the Department of Justice's Office of Justice Programs,which also includes the Bureau of Justice
Statistics,the National Institute of Justice,the Office of Juvenile Justice and Delinquency
Prevention,the Office for Victims of Crime,and the SMART Office. Points of view or opinions in
this document are those of the author and do not necessarily represent the official position or
policies of the U.S. Department of Justice."
The current edition of the DOJ Grants Financial Guide provides guidance on allowable printing and
publication activities.
36. Justification of consultant rate
A detailed justification must be submitted to and approved by the HCA Contract Manager prior to
obligation or expenditure of any consultant rate in excess of$650 per day.
37. Contractor understands and agrees that it must cooperate with HCA to allow HCA to to submit
quarterly Federal Financial Reports(SF-425)and semi-annual performance reports through GMS
(https://grants.ojp.usdoj.gov), and quarterly performance metrics reports through B1A's
Performance Measurement Tool(PMT)website(https://bjapmt.ojp.gov/).
For more detailed information on reporting and other requirements, refer to BJA's website. Failure
to cooperate with HCA to submit required reports by established deadlines may result in the
freezing of Contract funds and a High-Risk designation by HCA.
38. Contractor understands and agrees that,to the extent that substance abuse treatment and related
services are funded by this Contract,they will include needed treatment and services to address
opioid abuse reduction.
39. Categorical exclusion for Residential Substance Abuse Treatment (RSAT) Programs
None of the following activities will be conducted whether under the Office of Justice Programs
federal action or a related third-party action:
a. New construction.
b. Any renovation or remodeling of a property located in an environmentally or historically
sensitive area, including property(a)listed on or eligible for listing on the National Register
of Historic Places,or(b)located within a 100-year flood plain, a wetland,or habitat for an
endangered species.
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID:FE 1 F2FC2-0500-4C5F-BDB7-207624628C21
c. A renovation that will change the basic prior use of a facility or significantly change its size.
d. Research and technology whose anticipated and future application could be expected to
have an effect on the environment.
e. Implementation of a program involving the use of chemicals.
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID FEIF2FC2-0500-4C5F-BDB7-207624628C21
SCHEDULE A-2
Statement of Work
October 1, 2024 - September 30, 2025
1. Work Requirements
a Engage incarcerated individuals in the RSAT program. both in-custody and in
the community.
1. Focus on incarcerated individual's substance use disorder and mental health
diagnosis and other behavioral health-related needs.
2. Use a standardized, risks and needs screening instrument to help determine
program eligibility.
3. Determine necessary services in accordance with an American Society of
Addiction Medicine (ASAM) assessment.
4. Develop the RSAT offender's cognitive, behavioral, social, vocational, and
other skills to solve the substance abuse and related problems.
5. Provide staff of a chemical dependency treatment staff certified by the State
of Washington per Washington Administrative Code (WAC) 388-805.
i. Contractors can subcontract with a known and credible behavioral
health treatment agency to best coordinate the identification of, and
treatment for. individuals who are currently in custody and in need of
behavioral health treatment.
ii. Contractors can hire their own behavioral health staff, who hold and
maintain a Substance Use Disorder Professional license in the State of
Washington, or holds and maintain a Substance Use Disorder
Professional Trainee license AND have an approved Substance Use
Disorder Professional Supervisor, fully licensed in the state of
Washington, on staff in the facility. (Please see Title 18 RCW for
further details in licensure requirements).
6. Provide evidence-based substance use treatment, including medications to
treat opioid use disorder and withdrawal management, in accordance with
Attachment 8, Standard of Care for Opioid Use Disorder.
7. Develop individualized treatment plans that are periodically update with
progress and amended accordingly.
i. Provide Medications for treatment of Opioid Use Disorder(MOUD).
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID.FE1 F2FC2-0500-4C5F-BD67-207624628C21
ii. Provide a designated housing space, separate from the general
population, for RSAT participants.
iii. Require random urinalysis and/or other proven reliable forms of drug
and alcohol testing for the RSAT participants throughout the duration
RSAT program.
iv. Assess for aftercare needs and schedule follow-up appointments with
community agencies prior to individual's departure.
v. Prepare inmates for successful community reintegration, including
scheduled and confirmed post-release appointments for after care
treatment and services.
vi. Ensure each RSAT offender is enrolled in aftercare services upon their
release from jail with an outpatient community substance abuse
treatment facility certified by the State of Washington per Washington
Administrative Code (WAC) 388-805.
vii. Track the re-offense records of RSAT graduates for one (1) year.
2. Reporting Requirements
a. Program Plan Report. Contractor will provide report to HCA Contract Manager
for approval. Report will include, but not limited to, the following:
1. Current staffing/hiring,
2. Purchase of program supplies,
3. Status of subcontracts or Memorandums of Understanding (MOU);
4. Other components, as approved by HCA Contract Manager.
b. Quarterly Reports.
1. HCA Contract Manager will provide Contractor with report template within 10
days of contract execution.
2. Contractor will use template to complete reports and provide to HCA
Contract Manager for approval.
3. Contractor will comply with the following DOJ/BJA reporting requirements in
collaboration with the HCA DBHR.
i. No personal identifiable information;
ii. Numbers served/completing the program are required.
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05
Docusign Envelope ID:FE 1 F2FC2-0500-4C5F-BDB7-207624628C21
iii. Recidivism data, to include probation violation and new arrest
convictions:
iv. HCA will report this information to the DOJ/BJA as part of the reporting
requirements of the grant.
c. Report Components. The following is a list of required report components, in
accordance with the federal Bureau of Justice Assistance(BJA) all of which are
elaborated on in Attachment 7, Quarterly Report Template.
1. Average treatment cost per individual who receives program services.
2. Average length of stay in the program for incarcerated individuals
completing the program.
3. Number of participants carried over from the previous reporting period and
number of new participants.
4. The number of participants who successfully completed the program and
number of participants who were terminated or dropped out.
5. The number of new treatment beds and the percentage of them funded with
DOJ grant.
6. The number of days of residential treatment provided.
7. The number of participants completing the program who passed drug-
testing.
8. The number of participants who were screened or enrolled in Medicaid.
9. Criminal recidivism of participants who successfully completed the program.
10. Criminal recidivism of participants who were unsuccessfully discharged from
the program.
d. Narrative. Narrative program analysis/evaluation reports responding to the
oro g questions:
1 What were your accomplishments during this reporting period?
2. What goals were accomplished as they relate to your grant application?
3 What problems/barriers did you encounter, if any, within the reporting
period that prevented you from reaching your goals or milestones?
4. Is there any assistance that BJA can provide to address any
problems/barriers identified in question #3?
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No K4880-05
Docusign Envelope ID:FEIF2FC2-0500-4C5F-BDB7-207624628C21
5. Are you on track to fiscally and programmatically complete your program
as outlined in your grant application? (Please answer YES or NO and if no,
please explain.)
6. What major activities are planned for the next 6 months?
7. Based on your knowledge of the criminal justice field. are there any
innovative programs/accomplishments that you would like to share with
BJA?
3. Deliverables Table
1. Deliverables applicable for the period of October 1. 2024 to September 30,
2025.
escription Date Range Due Date ate ax Payment
1 3rogram Plan Applies to Quarters 1-4 10 days after 527,831 x 1 j$27,831
Report Icontract execution a ort
uarterly i�91: 10/1/2024- 12/31/2024 151h business day 532,667.25 1$130,669
Reports Q2 1/l/2025-3/31/2025 f each month er report x 4
Q3. 4/1/2025-6/30/2025 following the end eports
C64: 7/l/2025-9/30/2025 p f each quarter
Maximum Compensation for HCA Contract K4880-05 158,100
Washington State Substance Abuse Treatment Services
Health Care Authority HCA Contract No. K4880-05